Bariatric surgery is associated with greater long-term heart risk reduction than weight-loss medications

A Mayo Clinic study has found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk. The study is a direct comparison of two leading obesity treatments, evaluating how each approach affects the overall risk of cardiovascular disease. The findings are published in Annals of Surgery.